The ministry, on May 8, said the clinical trials of the drug, 2-deoxy-D-glucose (2-DG), showed that it helps in a faster recovery of hospitalised patients and reduces supplemental oxygen dependence. #DRDO #2DGMedicine #2DG #inmas #DRREDDY #rtpcr #Oxygen #OxygenShortage #COVID19 https://www.instagram.com/p/CO9wGY6jc1W/?igshid=19em9kcpyzssn















